Elevation Oncology, Inc.
NASDAQ:ELEV
0.5771 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -45.704 | -95.08 | -32.039 | -17.265 | -5.882 |
| Depreciation & Amortization
| 0.039 | 0.027 | 0.018 | 0.015 | 0 |
| Deferred Income Tax
| 5.855 | 0 | -1.637 | 5.137 | 0 |
| Stock Based Compensation
| 3.335 | 3.206 | 1.571 | 0.052 | 0.014 |
| Change In Working Capital
| -13.69 | 6.29 | 0.283 | 4.9 | 0.423 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -5.855 | 0.711 | -0.03 | 5.219 | 0.46 |
| Other Working Capital
| -7.835 | 5.579 | 0.313 | -0.319 | -0.037 |
| Other Non Cash Items
| -6.015 | 0.074 | 1.637 | -5.137 | -0.451 |
| Operating Cash Flow
| -56.18 | -85.483 | -30.167 | -12.298 | -5.45 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| 0 | -0.086 | 0 | -0.071 | 0 |
| Acquisitions Net
| 0 | 0.044 | 0 | 0 | 0 |
| Purchases Of Investments
| -42.657 | -112.312 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 54.2 | 68 | 0 | 0 | 0 |
| Other Investing Activites
| 0.012 | -0.044 | 0 | 0 | 0 |
| Investing Cash Flow
| 11.543 | -44.398 | 0 | -0.071 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | -0.47 | 0 | 0 | 0 |
| Common Stock Issued
| 47.999 | 0.019 | 97.062 | 0.02 | 7.19 |
| Common Stock Repurchased
| -0.024 | -0.035 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 47.999 | 30 | -0.011 | 90.009 | 10.785 |
| Financing Cash Flow
| 47.975 | 29.514 | 97.051 | 90.029 | 7.19 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 3.338 | -100.367 | 66.884 | 77.66 | 1.74 |
| Cash At End Of Period
| 49.255 | 45.917 | 146.284 | 79.4 | 1.74 |